Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications.

Elife · 2023 · PMC10666931 · PMID 37995198

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

eLife eLife 10.7554/eLife.91645.2.sa2 Reviewer #2 (Public Review): Anonymous Reviewer The paper nicely demonstrates the extent of the issue with the unreliability of commercial antibodies and describes a highly significant initiative for the robust validation of antibodies and recording this data so that others can benefit.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.